Physician profile
Jaclyn Carlisle Hoover
NPI 1295399699
$16,978.70
in general payments reported to CMS, 2019-2025
27 companies · $958 in 2025
The $958 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $3,813 · 2022: $11K · 2023: $1,034 · 2024: $459 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $6,110.38 | 2021-2023 | |
| Arthrex, INC. | $4,581.47 | 2022 | |
| Stryker Corporation | $2,643.53 | 2022-2025 | Actishield, Ortholoc 3di, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $826.67 | 2022 | |
| Next Science LLC | $805.65 | 2022-2023 | Surgx, Blastx, Xperience |
| Smith+Nephew, INC. | $417.29 | 2021-2025 | Footprint, Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Integra Lifesciences Corporation | $401.53 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanara Medtech INC. | $190.30 | 2023 | Celleraterx |
| E.R. Squibb & Sons, L.L.C. | $121.66 | 2025 | Reblozyl |
| Bone Support INC. | $120.03 | 2020 | |
| Linvatec Corporation | $102.70 | 2021 | |
| Aroa Biosurgery Incorporated | $101.72 | 2024 | |
| Paragon 28, INC. | $92.26 | 2024 | |
| Globus Medical, INC. | $53.43 | 2025 | Senza |
| Zimvie INC. | $53.17 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $52.50 | 2025 | Bio-Connekt |
| Bioventus LLC | $52.35 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $50.80 | 2024-2025 | |
| Nevro Corp. | $35.16 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $31.46 | 2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $30.99 | 2024 | Juggerknotless Soft Anchor |
| Embody, INC. | $24.67 | 2022 | |
| Averitas Pharma INC. | $18.62 | 2024 | Qutenza |
| Amgen INC. | $16.93 | 2024 | Krystexxa |
| Cashflow Solutions, LLC | $14.84 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Orthofix Medical, INC. | $14.41 | 2025 | Physio-Stim |
| Organogenesis INC. | $14.18 | 2024 | Affinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Hoover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.